Prevalence of Monoclonal Gammopathy in Wild‐Type Transthyretin Amyloidosis

[1]  C. Rapezzi,et al.  Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths , 2017, European heart journal.

[2]  James C Moon,et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.

[3]  M. Skinner,et al.  Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study , 2016, Circulation.

[4]  M. Halushka,et al.  Relationship between monoclonal gammopathy and cardiac amyloid type. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[5]  A. Petrie,et al.  Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome , 2013, Journal of the American Heart Association.

[6]  A. Dispenzieri,et al.  Erratum: Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: A retrospective population-based cohort study (Lancet (2010) 375 (1721-1728)) , 2010 .

[7]  T. Therneau,et al.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study , 2010, The Lancet.

[8]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[9]  G. Mead,et al.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[10]  A. Órfão,et al.  New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. , 2007, Blood.

[11]  Terry M Therneau,et al.  Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.

[12]  J. Trojanowski,et al.  Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.

[13]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[14]  A. López-Guillermo,et al.  Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance , 1992, British journal of haematology.

[15]  J. Lazarchick,et al.  Senile transthyretin cardiac amyloidosis in patients with plasma cell dyscrasias: importance of cardiac biopsy for making the correct diagnosis. , 2014, Aperito journal of cellular and molecular biology.